Kenson61
liked and commented on
$Novavax(NVAX.US$
May 13, 2024
GAITHERSBURG, Md., May 13, 2024 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced it will participate in the BofA Securities 2024 Health Care Conference.
May 13, 2024
GAITHERSBURG, Md., May 13, 2024 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced it will participate in the BofA Securities 2024 Health Care Conference.
5
1
Kenson61
liked
$Novavax(NVAX.US$ Damn so close to breaking 3.70 again! Stopped right on it! Grrrr! Hehehe! Just have to see if it will make a run at it again?
1
2
Kenson61
voted
Morning Mooers, the meme stock market screamed "We are so back" over the weekend, after Roaring Kitty, short squeezing enthusiast and financial influencer that helped inspire the original GameStop craze in 2021, finally tweeted again. Overnight $GameStop (GME.US)$ shot up 70%, and jumped 110% at open, hitting multiple circuit breakers.
Other meme stocks were flying as well on high volume.$Reddit (RDDT.US)$ climbed 8%, $AMC Entertainment (AMC.US)$ grew 14%. H...
Other meme stocks were flying as well on high volume.$Reddit (RDDT.US)$ climbed 8%, $AMC Entertainment (AMC.US)$ grew 14%. H...
25
5
Kenson61
reacted to
$Novavax(NVAX.US$
Amaaazzzing!
Who said its going below 1? Please comment below and justify your basis please so you can educate the public on your ignorance
Amaaazzzing!
Who said its going below 1? Please comment below and justify your basis please so you can educate the public on your ignorance
9
5
$Novavax(NVAX.US$ 10 yuan is too cheap. Go to 50
Translated
Kenson61
reacted to and voted
$Novavax(NVAX.US$
In 2024, Novavax's development reached a new climax, and the company's stock price and business development showed impressive performance. From a $1.2 billion vaccine license agreement with Sanofi to plans to promote its JN.1 protein-based non-mRNA COVID-19 vaccine globally, Novavax has certainly taken a place in the global biotech industry. In this context, many investors may be asking: is Novavax's stock still worth buying at the current price of $8-10?
Strong market dynamics
Novavax not only soared more than 99% in the first quarter of 2024, but also announced strong financial results. All of this further strengthened the market's confidence in its business model after the company reached a major vaccine licensing agreement with Sanofi. This type of collaboration provides a continuous revenue stream, while also showing Novavax's competitiveness and brand influence in the global vaccine market.
Innovative vaccine development
Additionally, the World Health Organization (WHO) recommended Novavax's JN.1 COVID-19 vaccine, which not only recognized its technology and product effectiveness, but also opened the door to the upcoming fall vaccine market. According to the company's latest non-clinical data, JN...
In 2024, Novavax's development reached a new climax, and the company's stock price and business development showed impressive performance. From a $1.2 billion vaccine license agreement with Sanofi to plans to promote its JN.1 protein-based non-mRNA COVID-19 vaccine globally, Novavax has certainly taken a place in the global biotech industry. In this context, many investors may be asking: is Novavax's stock still worth buying at the current price of $8-10?
Strong market dynamics
Novavax not only soared more than 99% in the first quarter of 2024, but also announced strong financial results. All of this further strengthened the market's confidence in its business model after the company reached a major vaccine licensing agreement with Sanofi. This type of collaboration provides a continuous revenue stream, while also showing Novavax's competitiveness and brand influence in the global vaccine market.
Innovative vaccine development
Additionally, the World Health Organization (WHO) recommended Novavax's JN.1 COVID-19 vaccine, which not only recognized its technology and product effectiveness, but also opened the door to the upcoming fall vaccine market. According to the company's latest non-clinical data, JN...
Translated
3
2
Kenson61
reacted to
$Novavax(NVAX.US$ we have officially traded the entire free float in just a couple hours. Once this locks we could see triple digits. this thing went from $10 to $100-300 three times in the last couple years.
24
1
Kenson61
reacted to
$Novavax(NVAX.US$
novavax is finally backed by pharma thats as big as pfizer.
more than half the shares are held by diamond hands institutional.
and of course die hard retailors like me … who sink down to 3.5 and continue to hold on .
80 here we come !
novavax is finally backed by pharma thats as big as pfizer.
more than half the shares are held by diamond hands institutional.
and of course die hard retailors like me … who sink down to 3.5 and continue to hold on .
80 here we come !
3
1
Kenson61
reacted to and commented on
$Novavax(NVAX.US$ Sanofi Signs $1.2 Billion Vaccine Licensing Deal With Novavax
Sanofi has the sole license to use Novavax’s protein-based Covid shot in combination with its flu shot. , Bloomberg
(Bloomberg) -- Sanofi and Novavax Inc. signed a licensing agreement that includes commercializing a combined Covid-19 and flu shot.
Novavax will receive $500 million in upfront payments as well as $700 million in development, regulatory and launch milestones, according to a statemen...
Sanofi has the sole license to use Novavax’s protein-based Covid shot in combination with its flu shot. , Bloomberg
(Bloomberg) -- Sanofi and Novavax Inc. signed a licensing agreement that includes commercializing a combined Covid-19 and flu shot.
Novavax will receive $500 million in upfront payments as well as $700 million in development, regulatory and launch milestones, according to a statemen...
4
17